St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 9, 2025

December 9, 2025

Two-Year Cardiac Study Published in JHLT Reveals Long-Term Survival Benefits with Advanced Heart Preservation

GlobeNewswire

December 9, 2025

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

GlobeNewswire

December 9, 2025

Clene to Present at the Emerging Growth Conference

GlobeNewswire

December 9, 2025

Cedar Gate Introduces Next-Generation Solutions for Prospective Bundled Payment Models

GlobeNewswire

December 9, 2025

YPrime Wins Two Clinical Trials Arena Excellence Awards for Innovation in AI and Sustainable eCOA Practices

GlobeNewswire

December 9, 2025

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing

GlobeNewswire

December 9, 2025

Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

December 9, 2025

Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment

GlobeNewswire

December 9, 2025

A.D.A.M. Innovations Announces the Launch of ALUNAÉ

GlobeNewswire

December 9, 2025

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico

GlobeNewswire

December 9, 2025

FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact

GlobeNewswire

December 9, 2025

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026

GlobeNewswire

December 9, 2025

Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use

GlobeNewswire

December 9, 2025

Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism

GlobeNewswire

December 9, 2025

Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

GlobeNewswire

December 9, 2025

LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices

GlobeNewswire

December 9, 2025

Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System

GlobeNewswire

December 9, 2025

AnswersNow Expands Virtual Autism Therapy and Caregiver Training Services to Colorado

GlobeNewswire

December 9, 2025

PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan

GlobeNewswire

December 9, 2025

Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

GlobeNewswire